Momenta Pharmaceuticals Inc - Company Profile

Powered by

All the data and insights you need on Momenta Pharmaceuticals Inc in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Momenta Pharmaceuticals Inc Strategy Report

  • Understand Momenta Pharmaceuticals Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Momenta Pharmaceuticals Inc: Overview

Select Item

Momenta Pharmaceuticals Inc (Momenta) is a biotechnology company which specializes in the structural analysis, characterization, and design of complex pharmaceuticals. The company’s marketed products include Glatopa and Enoxaparin Sodium Injection. Its pipeline portfolio includes biosimilar as well its own novel product candidates. The company utilizes its technology such as Sialylation platform and SIFbody platform for developing generic versions, biosimilars, complex drugs, and potentially interchangeable biologics, and also in the discovery and development of therapeutics for various cancers and autoimmune indications. The company markets its products through its collaborative partners. Momenta is headquartered in Cambridge, Massachusetts, the US.

 Gain a 360-degree view of Momenta Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Momenta Pharmaceuticals Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 301 Binney Street, Cambridge, Massachusetts, 02142
Website www.momentapharma.com
Telephone 1 617 4919700
Industry Pharmaceuticals and Healthcare
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Momenta Pharmaceuticals Inc premium industry data and analytics

20+

Pipeline Drugs

Identify which of Momenta Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

19+

Catalyst Calendar

Proactively evaluate Momenta Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

18+

Clinical Trials

Determine Momenta Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

11+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products
Marketed:
Glatiramer Acetate Injection
Enoxaparin Sodium Injection
XYZ
XYZ
XYZ
Understand Momenta Pharmaceuticals Inc portfolio and identify potential areas for collaboration Understand Momenta Pharmaceuticals Inc portfolio and identify potential areas for collaboration Find out more
Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Momenta Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into Momenta Pharmaceuticals Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward